Source comparison
Best CJC-1295 No DAC Dosage Recovery 2026: Protocol Comparison
| Protocol | Dose per Injection | Frequency | Weekly Total | Injection Timing | Typical Use Case | Professional Assessment ||—|—|—|—|—|—|| High-Frequency Protocol | 100mcg | 3×/week (M/W/F) | 300mcg | 30 min post-training or pre-sleep | General tissue repair r
This comparison does not assign a generated winner or score.
- | Protocol | Dose per Injection | Frequency | Weekly Total | Injection Timing | Typical Use Case | Professional Assessment ||—|—|—|—|—|—|| High-Frequency Protocol | 100mcg | 3×/week (M/W/F) | 300mcg | 30 min post-training or pre-sleep | General tissue repair research, sustained IGF-1 elevation | Best for maintaining consistent receptor sensitivity; lower per-dose side effect risk || Moderate Protocol | 150–200mcg | 2×/week (72–96hr spacing) | 300–400mcg | Post-training preferred | Acute injury recovery models, localized tissue repair | Higher pulse amplitude per dose; requires precise timing to avoid receptor desensitization || Single Weekly Dose | 300mcg | 1×/week | 300mcg | Post-training only | Not recommended | Insufficient frequency to maintain IGF-1 elevation; GH pulse returns to baseline within 48 hours || Daily Microdosing | 50mcg | 7×/day | 350mcg | Pre-sleep only | Experimental protocols | High risk of receptor downregulation; no documented advantage over 2–3×/week protocols |